Kilic, L.; Erden, A.; Sener, Y.Z.; Armagan, B.; Sari, A.; Kalyoncu, U.; Karadag, O.; Akdogan, A.; Dogan, I.; Apras Bilgen, S.;
et al. Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis. Biomolecules 2018, 8, 136.
https://doi.org/10.3390/biom8040136
AMA Style
Kilic L, Erden A, Sener YZ, Armagan B, Sari A, Kalyoncu U, Karadag O, Akdogan A, Dogan I, Apras Bilgen S,
et al. Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis. Biomolecules. 2018; 8(4):136.
https://doi.org/10.3390/biom8040136
Chicago/Turabian Style
Kilic, Levent, Abdulsamet Erden, Yusuf Ziya Sener, Berkan Armagan, Alper Sari, Umut Kalyoncu, Omer Karadag, Ali Akdogan, Ismail Dogan, Sule Apras Bilgen,
and et al. 2018. "Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis" Biomolecules 8, no. 4: 136.
https://doi.org/10.3390/biom8040136
APA Style
Kilic, L., Erden, A., Sener, Y. Z., Armagan, B., Sari, A., Kalyoncu, U., Karadag, O., Akdogan, A., Dogan, I., Apras Bilgen, S., Kiraz, S., & Ertenli, I.
(2018). Rituximab Therapy in Renal Amyloidosis Secondary to Rheumatoid Arthritis. Biomolecules, 8(4), 136.
https://doi.org/10.3390/biom8040136